柳药集团
(603368)
| 流通市值：66.92亿 | | | 总市值：67.21亿 |
| 流通股本：3.97亿 | | | 总股本：3.99亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 5,316,977,105.59 | 21,182,454,178.26 | 15,992,976,622.19 | 10,641,992,346.59 |
| 营业收入 | 5,316,977,105.59 | 21,182,454,178.26 | 15,992,976,622.19 | 10,641,992,346.59 |
| 二、营业总成本 | 4,972,816,882.83 | 20,166,805,761.4 | 15,081,535,497.52 | 10,030,636,921.1 |
| 营业成本 | 4,677,904,464.93 | 18,774,823,172.61 | 14,111,707,954.78 | 9,385,063,709.77 |
| 税金及附加 | 12,871,325.65 | 63,599,669.94 | 41,658,315.77 | 28,748,300.38 |
| 销售费用 | 126,347,302.05 | 629,684,429.75 | 430,997,572.17 | 285,325,562.89 |
| 管理费用 | 95,492,260.09 | 423,863,503.09 | 299,281,950.74 | 195,156,038.88 |
| 研发费用 | 9,274,653.84 | 39,629,592.29 | 21,663,634.24 | 14,008,342.08 |
| 财务费用 | 50,926,876.27 | 235,205,393.72 | 176,226,069.82 | 122,334,967.1 |
| 其中:利息费用 | 48,303,306.57 | 214,545,031.94 | 163,986,547.99 | 109,845,297.91 |
| 其中:利息收入 | 8,529,694.34 | 36,925,040.37 | 29,857,128.68 | 18,803,406.6 |
| 加:投资收益 | -1,262.62 | -95,285.99 | -10,900.22 | -45,066.81 |
| 资产处置收益 | 32,760.98 | 3,025,141.41 | 599,416.36 | 735,970.29 |
| 信用减值损失(新) | -39,623,890.99 | -32,119,064.88 | -70,143,170.84 | -55,063,393.33 |
| 其他收益 | 5,436,390.28 | 17,138,770.52 | 12,994,850.47 | 6,926,708.26 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 310,004,220.41 | 1,003,597,977.92 | 854,881,320.44 | 563,909,643.9 |
| 加:营业外收入 | 1,018,001.03 | 14,587,726.06 | 4,432,545.67 | 2,900,167.01 |
| 减:营业外支出 | 479,612.07 | 15,049,521.14 | 2,639,776.07 | 1,755,296.2 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 310,542,609.37 | 1,003,136,182.84 | 856,674,090.04 | 565,054,514.71 |
| 减:所得税费用 | 32,852,201.59 | 135,601,795.28 | 111,135,446.93 | 74,281,157.53 |
| 六、净利润 | 277,690,407.78 | 867,534,387.56 | 745,538,643.11 | 490,773,357.18 |
| 持续经营净利润 | 277,690,407.78 | 867,534,387.56 | 745,538,643.11 | 490,773,357.18 |
| 归属于母公司股东的净利润 | 277,335,135.88 | 854,872,384 | 715,908,021.45 | 464,193,662.02 |
| 少数股东损益 | 355,271.9 | 12,662,003.56 | 29,630,621.66 | 26,579,695.16 |
| (一)基本每股收益 | 0.7 | 2.21 | 1.87 | 1.24 |
| (二)稀释每股收益 | 0.7 | 2.21 | 1.87 | 1.24 |
| 九、综合收益总额 | 277,690,407.78 | 867,534,387.56 | 745,538,643.11 | 490,773,357.18 |
| 归属于母公司股东的综合收益总额 | 277,335,135.88 | 854,872,384 | 715,908,021.45 | 464,193,662.02 |
| 归属于少数股东的综合收益总额 | 355,271.9 | 12,662,003.56 | 29,630,621.66 | 26,579,695.16 |
| 公告日期 | 2025-04-29 | 2025-03-27 | 2024-10-30 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |